RNF146 enhances olaparib sensitivity in triple-negative breast cancer via XRCC5 downregulation
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
PARP inhibition in cancer therapy
Breast Cancer Treatment Studies
BRCA gene mutations in cancer
Publication details
- Journal / source
- Biochemical and Biophysical Research Communications
- Volume
- 816
- Pages
- 153708–153708
- Publication date
- 31 March 2026
- Language
- EN